ANDA 204457, held by Midwest Medcl. Ammonia N-13.
As of Nov 16, 2026, ANDA 204457 (Ammonia N 13), held by Midwest Medcl, was first approved by FDA on Nov 18, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 18, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ammonia N 1330mCi-300mCi/8ML (3.75-37.5mCi/ML) ยท injectable;intravenous | Ammonia N-13 | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters